PIEZO1 and cholangiocarcinoma: Our analysis of pan‐cancer data from The Cancer Genome Atlas (TCGA) using the TIMER database revealed that FAM38A, encoding Piezo1, was overexpressed in a variety of cancers, notably BLCA, cholangiocarcinoma (CHOL), kidney renal clear cell carcinoma (KIRC), and liver hepatocellular carcinoma (LIHC) (Figure 3A).